Nixon Peabody
Bank of America
You are here:  Home  >  Agribusiness  >  Current Article

Oxnard’s Cure makes $20M buy of CBD firm

By   /   Tuesday, July 28th, 2020  /   No Comments

    Print       Email
Cure Pharmaceutical, an Oxnard-based public company working on drug delivery systems and cannabis therapies, said July 28 that it has agreed to acquire Sera Labs, a privately owned CBD company, in a 95-percent stock deal that includes $19 million in stock at $2.75 per share. Cure, which shares are traded over the counter, closed unchanged at…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

Leave a Reply

Your email address will not be published. Required fields are marked *

You might also like...

Inogen revenue falls, but Q2 earnings beat analyst estimates

Read More →